AS
HRMY icon

Altshuler Shaham’s Harmony Biosciences HRMY Stock Holding History

Altshuler Shaham’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-104
Closed -$4.16K – 397
2024
Q3 		$4.16K Buy
+104
New +$3.65K ﹤0.01% 228
2023
Q1 		– Sell
-1,011
Closed -$55.7K – 425
2022
Q4 		$55.7K Sell
1,011
-296
-23% -$16.3K ﹤0.01% 201
2022
Q3 		$57K Buy
1,307
+665
+104% +$32.4K ﹤0.01% 202
2022
Q2 		$31K Sell
642
-243
-27% -$10.9K ﹤0.01% 309
2022
Q1 		$43K Sell
885
-317
-26% -$12.9K ﹤0.01% 388
2021
Q4 		$51K Buy
+1,202
New +$47.9K ﹤0.01% 413

Other funds holding HRMY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VM
Valor Management Chicago, Illinois $181M AUM 6.67% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Altshuler Shaham's HRMY Position: Q4 2024 in Review

Altshuler Shaham sold out of Harmony Biosciences (HRMY) in Q4 2024, closing a stake of 104 shares — an estimated $4.16K sold.

Altshuler Shaham first reported a position in HRMY in Q4 2021 and held it in 6 quarters. The position peaked at $57K in Q3 2022. 247 funds tracked by Wall St. Rank hold HRMY as of Q4 2024.

  • Altshuler Shaham reported no remaining Harmony Biosciences position as of Q4 2024 after selling out during the quarter.
  • Altshuler Shaham sold 104 Harmony Biosciences shares in Q4 2024, an estimated $4.16K.
  • Altshuler Shaham first reported a position in Harmony Biosciences in Q4 2021 and held it in 6 quarters.
  • Altshuler Shaham's Harmony Biosciences position peaked at $57K in Q3 2022.
  • 247 funds tracked by Wall St. Rank held Harmony Biosciences as of Q4 2024.

Based on Altshuler Shaham's 13F filing for Q4 2024, filed 13 Feb 2025.